Bristol-Myers Squibb (BMY) FY2021 results: revenue $46.4 billion, up 9.1% on the year
Bristol-Myers Squibb Co. (BMY) reported revenue of $46.4 billion for fiscal 2021, the year ended 31 December 2021, up 9.1% on the year before. Net income was $7.0 billion, and diluted earnings per share $3.12. The figures are the company's own, from the 10-K it filed with the SEC on 9 February 2022.
Revenue
$46.4 billion
+9.1% on the year
FY2014FY2021
Operating margin
17.5%
-16.2% a year earlier
FY2014FY2021
Net income
$7.0 billion
FY2014FY2021
Diluted EPS
$3.12
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
16,207
14,052
8,210
+15.3%
Capital expenditure
973
753
836
+29.2%
Free cash flow
15,234
13,299
7,374
+14.5%
Free cash flow margin
32.8%
31.3%
28.2%
Cash from investing
-538
-10,859
-9,913
Cash from financing
-16,224
-1,151
7,621
Depreciation and amortisation
10,686
10,380
1,746
+2.9%
Share-based compensation
583
779
441
-25.2%
Buybacks
6,287
1,546
7,300
+306.7%
Dividends paid
4,396
4,075
2,679
+7.9%
Dividend per share
$2.01
$1.84
$1.68
+9.2%
Diluted shares, weighted
2,245m
2,258m
1,712m
-0.6%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
35,946
37,822
51,598
-5.0%
Non-controlling interest
60.0
60.0
100
0.0%
Short-term borrowings
4,948
n/a
n/a
Debt
44,369
50,676
46,733
-12.4%
Operating lease liabilities
874
833
672
+4.9%
Other liabilities
23,117
29,090
30,841
-20.5%
Total liabilities and equity
109,314
118,481
129,944
-7.7%
Fixed assets
6,049
5,886
6,252
+2.8%
Goodwill
20,502
20,547
22,488
-0.2%
Intangible assets
42,527
53,243
63,969
-20.1%
Investments
2,987
1,718
3,814
+73.9%
Cash and equivalents
13,979
14,546
12,346
-3.9%
Receivables
7,979
7,219
6,476
+10.5%
Inventory
2,095
2,074
4,293
+1.0%
Other assets
13,196
13,248
10,306
-0.4%
Total assets
109,314
118,481
129,944
-7.7%
10-K for the year ended 31 December 2021, filed 9 February 2022: the filing.